Publicacións (164) Publicacións nas que participase algún/ha investigador/a

2022

  1. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E

    Bladder Cancer, Vol. 8, Núm. 4, pp. 379-393

  2. A new, three-dimensional approach to the GOLD COPD assessment tool

    Respiratory Medicine and Research, Vol. 81

  3. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort

    European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801

  4. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial

    BMC medicine, Vol. 20, Núm. 1, pp. 83

  5. Abordaje Integral del Paciente con Heridas: herramienta el Pentágono más allá del triángulo de la herida

    Heridas y cicatrización: Revista de la Sociedad Española de Heridas, Vol. 12, Núm. 1, pp. 6-19

  6. Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry

    Leukemia Research, Vol. 115

  7. Adjusting RFR by Predictors of Disagreement, “The Adjusted RFR”: An Alternative Methodology to Improve the Diagnostic Capacity of Coronary Indices

    Arquivos Brasileiros de Cardiologia, Vol. 119, Núm. 5, pp. 705-713

  8. Advanced Maternal Age as an Obstetric Risk Factor: Current Experience in a Hospital from Northwestern Spain

    Acta Medica Portuguesa, Vol. 35, Núm. 13

  9. Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy: A Multicenter Observational Study

    Drug and Alcohol Dependence, Vol. 230

  10. Amiloidosis cardíaca por transtiretina: Características clínicas y evolución de 71 pacientes

    Galicia Clínica, Vol. 83, Núm. 2, pp. 60-60

  11. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

  12. Anaphylactic Shock to Mediterranean Silverside (Atherina boyeri) Caused by Nonparvalbumin Allergens

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 224-226

  13. Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 4, pp. 1020-1028

  14. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  15. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

  16. Análisis de la infección por SARS-COV2 en pacientes obstétricas: Complicaciones durante embarazo, parto y puerperio precoz

    Galicia Clínica, Vol. 83, Núm. 2, pp. 72-72

  17. Análisis de las interconsultas de los servicios quirúrgicos en el Hospital Lucus Augusti

    Galicia Clínica, Vol. 83, Núm. 2, pp. 68-68

  18. Aplicación de índices pronósticos para predecir el riesgo de mortalidad en pacientes con multimorbilidad y reingresos frecuentes

    Galicia Clínica, Vol. 83, Núm. 2, pp. 71-71

  19. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

    PLoS ONE, Vol. 17, Núm. 2 February

  20. Association between neuroimaging findings and neurological sequelae in patients with congenital cytomegalovirus infection

    Neurologia, Vol. 37, Núm. 2, pp. 122-129